Rosen Law Firm Investigates Losses for Disc Medicine Investors
Rosen Law Firm has initiated an investigation into potential securities class action claims on behalf of shareholders of Disc Medicine, Inc. The probe concerns allegations that Disc Medicine may have issued materially misleading information.
New York – September 16, 2026 – Rosen Law Firm, a global investor rights law firm, is continuing its investigation into potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON). The investigation centers on allegations that the company may have issued materially misleading statements to investors.
The law firm is encouraging investors who have experienced losses exceeding $100,000 in Disc Medicine stock to inquire about their rights. The probe aims to determine if the company violated securities laws through its disclosures, particularly concerning its therapeutic development.
Potential legal actions could target the company's management and board if responsibility for errors or omissions in public statements is established. Investors who have suffered significant financial losses and wish to explore their options are advised to contact Rosen Law Firm promptly.
This investigation reflects ongoing efforts to safeguard investor interests and ensure corporate accountability in the securities market.